Phase Ia/Ib dose-escalation study of the anti-TIGIT antibody tiragolumab as a single agent and in combination with atezolizumab in patients with advanced solid tumors

被引：20

作者：

Bendell, Johanna C. ^{[1
]}

Bedard, Philippe ^{[2
]}

Bang, Yung-Jue ^{[3
]}

LoRusso, Patricia ^{[4
]}

Hodi, Stephen ^{[5
]}

Gordon, Michael ^{[6
]}

D'Angelo, Sandra ^{[7
]}

Desai, Jayesh ^{[8
]}

Garralda, Elena ^{[9
]}

Italiano, Antoine ^{[10
]}

Myung-Ju Ahn ^{[11
]}

Cervantes, Andres ^{[12
]}

Wainberg, Zev ^{[13
]}

Calvo, Emiliano ^{[14
]}

Gil-Martin, Marta ^{[15
]}

Martinez-Garcia, Maria ^{[16
]}

Bahleda, Rastilav ^{[17
]}

Cassier, Philippe ^{[18
]}

Delord, Jean-Pierre ^{[19
]}

Prawira, Amy ^{[20
]}

Melero, Ignacio ^{[21
]}

Emens, Leisha ^{[22
]}

Romano, Emanuela ^{[23
]}

Miller, Karen ^{[24
]}

Hsieh, Robert W. ^{[25
]}

Xue, Cloris ^{[24
]}

Morrissey, Kari ^{[24
]}

Twomey, Patrick ^{[24
]}

Gash, Kelly ^{[24
]}

Patil, Namrata S. ^{[24
]}

Grogan, Jane ^{[24
]}

Meng, Raymond ^{[24
]}

Cho, Byoung ^{[26
]}

Kim, Tae Won ^{[27
]}

机构：

[1] Sarah Cannon Res Inst, Nashville, TN USA

[2] Princess Margaret Hosp, Toronto, ON, Canada

[3] Seoul Natl Univ Hosp, Seoul, South Korea

[4] Yale Canc Ctr, New Haven, CT USA

[5] Dana Farber Canc Inst, Boston, MA 02115 USA

[6] HonorHlth Res Inst, Scottsdale, AZ USA

[7] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[8] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[9] Hosp Univ Vall dHebron, Barcelona, Spain

[10] Inst Bergonie CLCC, Bordeaux, France

[11] Samsung Med Ctr, Seoul, South Korea

[12] Hosp Clin Univ Valencia, Valencia, Spain

[13] Univ Calif Los Angeles, Los Angeles, CA USA

[14] Hosp Univ HM Sanchinarro CIOCC, Madrid, Spain

[15] ICO Hosp, Barcelona, Spain

[16] Hosp del Mar, Barcelona, Spain

[17] Inst Gustave Roussy, Villejuif, France

[18] Ctr Leon Berard Ctr Reg Lutte Canc Rhone Alpes, Lyon, France

[19] Inst Claudius Regaud, Toulouse, France

[20] St Vincents Hosp, Darlinghurst, NSW, Australia

[21] Clin Univ Navarra, Navarra, Spain

[22] Johns Hopkins Univ, Baltimore, MD USA

[23] Inst Curie, Paris, France

[24] Genentech Inc, San Francisco, CA 94080 USA

[25] F Hoffmann La Roche, Mississauga, ON, Canada

[26] Sarah Cannon Res Inst, Seoul, South Korea

[27] Asan Med Ctr, Seoul, South Korea

来源：

CANCER RESEARCH | 2020年 / 80卷 / 16期

关键词：

D O I：

10.1158/1538-7445.AM2020-CT302

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CT302

引用

页数：3

共 50 条

[41] A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study
Dieras, Veronique
Bachelot, Thomas
Campone, Mario
Isambert, Nicolas
Joly, Florence
Le Tourneau, Christophe
Cassier, Philippe
Bompas, Emmanuelle
Fumoleau, Pierre
Noal, Sabine
Orsini, Christine
Jimenez, Marta
Imbs, Diane Charlotte
Chatelut, Etienne
ONCOLOGY AND THERAPY, 2016, 4 (02) : 211 - 223
[42] Phase I Dose-Escalation Study of Ramucirumab in Chinese Patients with Advanced Solid Tumors
Cao, Junning
Ji, Dongmei
Chen, Zhiyu
Shen, Weina
Wang, Jin
Li, Baoyue
Chi, Haidong
Long, Amanda
Gao, Ling
Li, Jin
ONCOLOGIST, 2017, 22 (06): : 638 - +
[43] Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors
Demetri, George D.
Lo Russo, Patricia
MacPherson, Lain R. J.
Wang, Ding
Morgan, Jeffrey A.
Brunton, Valerie G.
Paliwal, Prashni
Agrawal, Shruti
Voi, Maurizio
Evan, T. R. Jeffry
CLINICAL CANCER RESEARCH, 2009, 15 (19) : 6232 - 6240
[44] A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors
Silk, Ann W.
Saraiya, Biren
Groisberg, Roman
Chan, Nancy
Spencer, Kristen
Girda, Eugenia
Shih, Weichung
Palmeri, Marisa
Saunders, Tracie
Berman, Robert M.
Coric, Vlad
Chen, Suzie
Zloza, Andrew
Vieth, Joshua
Mehnert, Janice M.
Malhotra, Jyoti
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2022, 27 (01)
[45] A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors
Ann W. Silk
Biren Saraiya
Roman Groisberg
Nancy Chan
Kristen Spencer
Eugenia Girda
Weichung Shih
Marisa Palmeri
Tracie Saunders
Robert M. Berman
Vlad Coric
Suzie Chen
Andrew Zloza
Joshua Vieth
Janice M. Mehnert
Jyoti Malhotra
European Journal of Medical Research, 27
[46] A phase Ib dose-escalation study of eribulin mesylate in combination with capecitabine in patients with advanced/metastatic cancer
Nasim, Muhammad Yaser
Plummer, Ruth
Evans, T. R. Jeffry
Morrison, Rosemary
Anthoney, David Alan
Haney, Sophie
Madi, Ayman
Savulsky, Claudio Isaac
Johnston, Claire
Carter, David
Reyderman, Larisa
Gopalakrishna, Prashanth
Wanders, Jantien
Twelves, Christopher
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[47] Phase I pharmacokinetic, safety, and preliminary efficacy study of tiragolumab in combination with atezolizumab in Chinese patients with advanced solid tumors
Shemesh, Colby S.
Wang, Yongsheng
An, Andrew
Ding, Hao
Chan, Phyllis
Liu, Qi
Chen, Yih-Wen
Wu, Benjamin
Wu, Qiong
Wang, Xian
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 94 (01) : 45 - 55
[48] PHASE IB DOSE-ESCALATION STUDY OF THE AKT INHIBITOR IPATASERTIB (IPAT) WITH PACLITAXEL (P) IN PATIENTS (PTS) WITH ADVANCED SOLID TUMORS
Isakoff, S. J.
Infante, J. R.
Juric, D.
Chan, W. Y.
Jia, S.
Musib, L.
Zhu, J.
Meng, R.
Patel, P. H.
Bendell, J. C.
ANNALS OF ONCOLOGY, 2014, 25
[49] A dose-escalation study of oxaliplatin and vinorelbine in patients with advanced solid tumors
Kakolyris, S
Kouroussis, C
Koukourakis, M
Marvroudis, D
Malas, K
Vardakis, N
Bozionelou, V
Kalbakis, K
Georgoulias, V
ONCOLOGY, 2002, 63 (03) : 213 - 218
[50] A dose-escalation study of oxaliplatin and vinorelbine in patients with advanced solid tumors'
Kakolyris
ONCOLOGY, 2006, 71 (3-4) : 203 - 203

← 1 2 3 4 5 →